The financial trajectory of Revolution Medicines presents a fascinating case study in biotech investing, where soaring research expenditures and mounting...

The investment case for Goldman Sachs BDC presents a study in contrasts. While market analysts express growing caution, company leadership...

Corsair Gaming finds itself at a critical juncture as conflicting financial signals create uncertainty among investors. The gaming hardware manufacturer's...

The First Trust BuyWrite Income ETF (FTHI) presents investors with a compelling yet concentrated approach to generating income. This covered-call...

Nokia's latest financial results have delivered a positive surprise to investors, with the company's recent acquisition of Infinera proving to...

Grid Dynamics Holdings is implementing a significant change to its compensation structure, moving executive pay from cash to company stock....

Oppenheimer Holdings finds itself navigating conflicting currents as its latest financial results reveal a company caught between impressive revenue expansion...

Aclaris Therapeutics witnessed a significant selloff in its stock price after releasing disappointing third-quarter 2025 financial results. The biotechnology firm...

The medical technology firm TransMedics continues to post impressive operational results, yet its share price tells a conflicting story. Despite...

Amid market turbulence, Hercules Capital has positioned itself as a defensive play with an attractive dividend yield. However, a closer...